FY 2027 IPPS Final Rule: What Hospitals Need to Know Before October 1

---------------------------

The FY 2027 IPPS Final Rule is more than an annual payment update. For hospitals, its impact will reach from the coding department and CDI team to reimbursement, quality reporting, and revenue cycle operations.

CMS issued the FY 2027 Hospital Inpatient Prospective Payment System (IPPS) Final Rule on July 31, 2026, with most of its key payment and coding changes taking effect October 1, 2026. The final rule includes updates to Medicare payment rates, MS-DRGs, ICD-10-CM and ICD-10-PCS coding, New Technology Add-On Payments (NTAP), quality reporting, and other hospital policies.

For hospitals preparing for the new fiscal year, however, the biggest takeaway may be less about the sheer number of changes and more about how those changes interact.

A new diagnosis code can affect severity classification. A revised MS-DRG can change expected reimbursement. A documentation gap can prevent the clinical picture from being accurately represented. And a technology that qualifies for an additional payment requires more than simply knowing that the payment exists—it requires the right codes, documentation, and billing processes to support it.

In other words, October 1 is not just a code-set changeover. It is a revenue cycle transition point.

The Payment Update Is Only the Starting Point

For FY 2027, CMS finalized a 2.3% increase in IPPS payment rates for hospitals that meet the applicable Hospital Inpatient Quality Reporting (IQR) and meaningful EHR requirements. The update reflects a projected 3.2% hospital market basket increase, reduced by a 0.9 percentage-point productivity adjustment. CMS estimates that the finalized changes will increase hospital payments by approximately $2.1 billion overall.

That headline number provides useful context, but it should not be interpreted as a uniform increase for every hospital or every inpatient case.

IPPS reimbursement remains influenced by factors such as the MS-DRG assigned to the case, wage index, case mix, outlier payments, and other applicable adjustments. CMS also estimates approximately $779 million in additional FY 2027 payments associated with inpatient cases involving new medical technologies, primarily because of newly approved NTAPs.

For revenue cycle leaders, this reinforces an important point: a payment-rate increase does not eliminate the need to protect payment accuracy at the individual claim level.

The reimbursement opportunity still depends on whether the clinical story is accurately documented, coded, grouped, and submitted.

ICD-10-CM: Fewer Additions, but Plenty of Operational Impact

The FY 2027 ICD-10-CM update contains 190 new codes, 30 deleted codes, and four revised code titles, effective October 1, 2026.

The number of new codes is lower than in FY 2026, but that should not be mistaken for a low-impact update.

Several changes introduce greater specificity that can affect coding workflows and documentation review. Among the notable additions are 33 codes related to continuing pregnancy after vanishing twin syndrome, new codes for prevesical and other pelvic abscesses, greater specificity for selected ectopic pregnancies, new low-BMI codes, additional cardiovascular specificity, and new codes involving gender transition history and gender identity disorder in remission.

The low-BMI change is a particularly good example of why code updates should not be viewed simply as a list of new numbers.

When a broad code is replaced by more specific choices, organizations need to consider whether the clinical documentation and coding workflow provide enough information to support the new level of specificity.

That means the October 1 preparation process should involve more than loading the new code set into an encoder or EHR.

ICD-10-PCS Brings Another Layer of Change

The FY 2027 ICD-10-PCS update includes 101 new procedure codes and 38 deletions, bringing the total number of PCS codes to 79,256.

The changes include new codes for procedures involving division of the aortic and mitral valves, custom-made interbody fusion devices, new technologies and computer-assisted procedures, wound management modalities, impeller pump procedures, and additional procedures involving extracorporeal or systemic assistance and performance.

Some of these changes may have a direct relationship to MS-DRG assignment, making PCS accuracy particularly important for hospitals performing complex surgical and technology-driven procedures.

This is where coding, CDI, and clinical documentation become increasingly interconnected.

A procedure cannot be accurately represented by the PCS code if the documentation does not adequately describe what was performed, the approach, the device or technology involved, and the other elements required by the classification system.

MS-DRGs: Where Coding Changes Can Become Payment Changes

The FY 2027 rule also makes substantial changes to the MS-DRG classification system.

Among the notable changes are new MS-DRGs addressing hip and knee procedures involving periprosthetic joint infection, new classifications for cardiac pacemaker revision or replacement, and changes involving extensive or complex spinal fusion procedures. CMS is also revising the treatment of several existing MS-DRGs and consolidating or replacing certain classifications.

For example, CMS finalized new MS-DRGs 403 and 404 for hip or knee procedures with a principal diagnosis of periprosthetic joint infection, with the severity structure reflecting MCC status and specified procedures. CMS also finalized new base MS-DRGs for knee procedures with a principal diagnosis of infection and revision of hip or knee prostheses.

There are also new MS-DRGs 210 and 211 for cardiac pacemaker revision or device replacement, as well as new classifications for extensive or complex spinal fusion procedures.

These changes illustrate why simply memorizing the new MS-DRG numbers is not enough.

The more important question for a hospital is: Are our documentation, coding, and grouping processes accurately identifying the cases that belong in these classifications?

That is a CDI and revenue integrity question as much as it is a coding question.

MCC and CC Changes Deserve a Closer Look

The FY 2027 rule also changes the severity classification of several diagnoses.

Three notable conditions are being added to the MCC list: pulmonary mycetoma, prevesical abscess, and other pelvic abscess.

These additions create new opportunities for the clinical record to more precisely represent the severity of certain inpatient cases—but only when the diagnosis is supported by appropriate provider documentation and correctly coded.

At the same time, CMS is moving a group of diagnoses involving homelessness, inadequate housing, and housing instability from CC to NonCC for FY 2027. CMS explained that its updated analysis did not support retaining their CC designation under the methodology used to assess relative resource use.

That distinction is important.

The change does not mean these circumstances should disappear from the medical record or no longer be reported when clinically and operationally appropriate. It means their severity classification within the MS-DRG system is changing.

For CDI and coding teams, that is an important reminder to separate accurate clinical reporting from assumptions about reimbursement impact.

New Technology Payments: Don't Stop at Knowing the NTAP List

New Technology Add-On Payments remain another area where coding and reimbursement intersect.

CMS maintains specific implementation files identifying technologies that are newly approved, continuing, or discontinued for FY 2027. The FY 2027 MAC implementation file was updated as recently as September 18, 2026.

That means hospitals should not rely solely on an early summary of the final rule.

The operational question is whether the technology is eligible for an FY 2027 NTAP, associated with the appropriate ICD-10-PCS and/or diagnosis codes, properly documented in the medical record, captured through the hospital's charge and coding workflow, and reflected correctly on the final claim.

The final rule also illustrates how significant these payments can be for certain therapies. ZEVASKYN™ (prademagene zamikeracel), an autologous cell sheet-based gene therapy for recessive dystrophic epidermolysis bullosa, received FY 2027 NTAP status after CMS's final review.

The broader lesson is more important than any individual technology: NTAP is an additional reimbursement opportunity, but it still depends on operational execution.

A technology payment sitting in a CMS table does not automatically become revenue on a hospital's claim.

Quality Reporting Is Moving Alongside Coding and Payment

The FY 2027 IPPS rule also reinforces the fact that hospital revenue cycle operations cannot be separated entirely from quality reporting.

CMS finalized several changes to the Hospital Inpatient Quality Reporting Program, including three new measures: Excess Days in Acute Care After Hospitalization for Diabetes, beginning with the FY 2029 payment determination; Hospital Harm–Postoperative Venous Thromboembolism eCQM, beginning with FY 2030; and Advance Care Planning eCQM, beginning with FY 2030.

CMS is also modifying several existing measures and adding Medicare Advantage data to certain claims-based measures.

Separately, CMS finalized a new sepsis-related readmission measure for the Hospital Readmissions Reduction Program, with confidential early-look reporting preceding its use in payment calculations beginning with the FY 2030 program year.

The significance for hospitals is the lead time.

Some of these measures will not affect payment immediately. But the data collection, workflow, documentation, and reporting infrastructure needed to support them may need to begin much earlier.

What Should Hospitals Be Doing Before October 1?

The most effective approach is to treat the FY 2027 transition as a cross-functional revenue cycle readiness exercise, rather than a coding department project.

At a minimum, hospitals should review:

Code-set readiness. Confirm that FY 2027 ICD-10-CM and ICD-10-PCS files, guidelines, encoder content, EHR configurations, edits, and billing systems are updated for the appropriate October 1 implementation.

High-impact code changes. Identify new, deleted, and restructured diagnosis and procedure codes that are relevant to the hospital's major service lines. The goal should be targeted education rather than asking every coder to absorb every change equally.

MS-DRG impact. Review the hospital's historical case mix against new and modified MS-DRGs. Particular attention should go to high-volume procedures and classifications where the severity structure or grouping logic has changed.

CDI alignment. Identify diagnoses where the new code structure or severity classification creates a need for more precise clinical documentation. Coding education without corresponding provider and CDI awareness can leave the underlying problem unresolved.

NTAP readiness. Create a technology-specific checklist covering eligibility, documentation, coding, charge capture, claim edits, and reimbursement validation.

Deleted-code controls. Don't just distribute a list of deleted codes. Search for them in EHR favorites, order sets, superbills, templates, encoder tools, charge masters, coding references, and internal billing rules.

Post-implementation monitoring. The first few weeks after October 1 should be treated as a monitoring period. Track rejected claims, coding queries, DRG shifts, unexpected reimbursement changes, and recurring documentation issues so that problems can be corrected before they become systemic.

Bristol's Perspective

At Bristol, we view annual IPPS changes as an example of why coding and revenue cycle management cannot operate in separate silos.

The FY 2027 rule contains hundreds of individual changes, but a hospital does not experience them as hundreds of separate regulatory events. They show up as claims, documentation questions, DRG assignments, payment variances, denials, quality-reporting requirements, and occasionally missed reimbursement opportunities.

That makes prioritization especially important.

A practical readiness strategy is to start with the hospital's own data: identify the highest-volume MS-DRGs, highest-value procedures, major service lines, common CC/MCC diagnoses, and technologies associated with additional payment opportunities. Then map the FY 2027 changes against those areas.

This turns a large regulatory document into a focused operational exercise.

The objective should not simply be to make sure coders know what changed on October 1. It should be to make sure the entire revenue cycle can translate the new rules into accurate documentation, coding, claims, reimbursement, and reporting.

The Bottom Line

The FY 2027 IPPS Final Rule takes effect at a familiar time—October 1—but its impact extends well beyond the first day of the new fiscal year.

With a 2.3% finalized IPPS payment update, significant MS-DRG revisions, 190 new ICD-10-CM codes, 101 new ICD-10-PCS codes, new MCC classifications, changes to CC designations, expanded NTAP opportunities, and evolving quality-reporting requirements, hospitals have several interconnected areas to address.

The organizations best positioned for a smooth transition will be those that start with impact rather than volume: identify what matters most to their patient population and reimbursement profile, connect coding changes to documentation and billing workflows, and monitor the results once the new rules go live.

October 1 may mark the implementation date. For hospital revenue cycle teams, the real preparation should already be underway.